日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial

BIO101 在有行动障碍风险的肌少症老年人中的应用:一项双盲随机干预性 2b 期试验的结果

Fielding, Roger A; Dao, Michael M; Cannon, Kevin; Desvarieux, Moise; Miller, Sam S; Gimness, Michael Paul; Brandon, Donald M; Villareal, Dennis T; Bruyere, Olivier; Bautmans, Ivan; Rickner, Kyle; Perry, Robert; Kritchevsky, Stephen B; Musi, Nicolas; Chehade, Joe M; Kirstein, Judith L; Gielen, Evelien; Pickrell, Paul; Dilda, Pierre; Lafont, Rene; Margalef, Carole; Rolland, Yves; Del Signore, Susanna; Mariani, Jean; Agus, Samuel; Tourette, Cendrine; Dioh, Waly; van Maanen, Rob; Veillet, Stanislas

Characterizing sarcopenia and sarcopenic obesity in patients aged 65 years and over, at risk of mobility disability: a multicenter observational trial (SARA-OBS).

对 65 岁及以上有行动障碍风险的患者进行肌少症和肌少症性肥胖症的特征分析:一项多中心观察性试验 (SARA-OBS)

Fielding Roger A, Rolland Yves, Bruyere Olivier, Desvarieux Moise, Donini Lorenzo M, Incalzi Raffaele Antonelli, Muscaritoli Maurizio, Tchalla Achille, Bonnefoy Marc, Rondanelli Mariangela, Van Maanen Rob, Mariani Jean, Margalef Carole, Del Signore Susanna, Tourette Cendrine, Dioh Waly, Veillet Stanislas